Clik here to view.
More Than Half of Doctors Refuse to See Reps
A recent report from ZS Associates affirms a decade-long decline in pharmaceutical rep access to physicians. The reasons are well known: doctors have busier schedules, they’re joining large practices...
View ArticleClik here to view.
The Land of Oz
Dr. Oz and celebrity doctors like him have stirred up the medical community. Regardless of what you think about the accuracy of Dr. Oz’s claims and advice, he has created a huge audience of four...
View ArticleClik here to view.
Is Big Pharma Losing Its Innovation Brand? Not so fast…
The list of leading consumer electronics and telecom companies that have embraced digital health this year are all household brands: Apple, Qualcomm, Google, Amazon, Samsung, Verizon and AT&T....
View ArticleClik here to view.
The Four Cs of Building a Customer-Centric Marketing Culture
I recently participated in the Digital Pharma East conference in Philadelphia. At this annual event, 200 to 300 pharma marketers and their agencies gather to talk about digital pharma and trade...
View ArticleClik here to view.
The Four Cs of Customer-Centric Marketing Culture, Part II
In the last blog post, I covered the first two Cs of Customer-Centric Marketing for pharma, Commitment and Courage. We need to make a Commitment to building a data and insight culture. This begins to...
View ArticleClik here to view.
Wrapping Services Around Products: The New Pharma Model
“The home is ultimately going to be the major site of care for all but the sickest patients.” This from an interview with George Halvorson, CEO of Kaiser Permanente, in which he expounds about...
View ArticleClik here to view.
On Creating a (Healthcare) Whole Bigger than the Sum
platform, noun 1. A raised level surface on which people or things can stand. When I think about a platform, especially in business, I imagine a foundation for building an integrated solution or a...
View ArticleClik here to view.
Pharma Moves Into Digital Health
The announcement that Novartis and Qualcomm Ventures have formed a joint venture to invest $100 million in digital health is significant and suggests that big pharma is transitioning from talk to...
View ArticleClik here to view.
Big Pharma Makes Moves To Manage Disruption
What I liked most about a recent HBR article was what wasn’t mentioned. The recent Harvard Business Review article, “How Merck is Trying to Keep Disrupters at Bay,” is all about disruption, and anyone...
View Article
